Ribaxa 150MG Tablet (60’s) is a prescription medication that contains Olaparib as its active ingredient, with each tablet delivering a potent dose of 150 mg. This drug is primarily utilized in the treatment of certain types of cancer, particularly ovarian cancer, breast cancer, and other malignancies associated with BRCA mutations. Olaparib belongs to a class of drugs known as PARP inhibitors, which work by interfering with the cancer cell’s ability to repair its DNA, ultimately leading to cell death. Ribaxa is formulated to provide a convenient oral dosage form, making it easier for patients to adhere to their treatment regimen. The composition of Ribaxa includes not only the active ingredient but also various excipients that aid in the tablet’s stability and absorption. As a targeted therapy, Ribaxa represents a significant advancement in cancer treatment, offering hope to patients with specific genetic profiles.